3Dynamic Systems
3Dynamic Systems develops affordable bioprinting systems for tissue engineering and regenerative medicine research.
- CEO / Founder
- Dr. Daniel J Thomas
- Team Size
- 10
- Stage
- R&D
- Total Funding
- Undisclosed
- Latest Round
- Venture Round
- Key Investors
- N/A (University spinout)
Technology & Products
Key Products
Alpha Series (bone tissue), Omega Series (soft tissue), Delta Carbon Fibre 3D Printer
Technological Advantage
University-developed technology; focus on ceramic matrix composites and bioprinting materials
Differentiation
Value Proposition
First commercial and affordable 3D bioprinting systems for creating functional human tissues.
How They Differentiate
Affordable entry point for bioprinting research; specialized in microtia treatment research
Market & Competition
Target Customers
Research institutions, universities, medical research labs
Industry Verticals
Bioprinting, Tissue Engineering, Medical Research, Pharmaceuticals
Competitors
CELLINK/Cytiva, Organovo, Allevi/3D Systems
Growth & Milestones
Growth Metrics
University spinout; First commercial affordable 3D bioprinting systems; Operating in growing $2.3B global bioprinting market (2023)
Major Milestones
Founded as Swansea University spinout; Developed first commercial affordable 3D bioprinting systems; Recognized as key player in global 3D bioprinting market alongside Organovo, Aspect Biosystems, Stratasys
Notable Customers
Research institutions, Universities, Pharmaceutical research labs, Tissue engineering researchers